Investors

Croda creates long-term value by engaging with our customers and markets wherever and whenever they need us - creating, making and selling sustainable and innovative speciality ingredients. We call this Smart science to improve lives™.

Find out more

Investors

We provide practical solutions to help address some of the world’s biggest challenges and are committed to becoming the most sustainable supplier of innovative ingredients. As part of this we will become Climate, Land and People Positive by 2030, having used the United Nations Sustainable Development Goals (SDGs) to underpin our approach.

This section tells you more about our goals, how we are achieving them, and the successes we have already achieved.

Contact Croda investor relations

Institutional investors

Please contact our Investor Relations team by email

Individual investors

Individual shareholder queries are dealt with by our Registrars, Link Asset Services. Contact details can be found in our shareholder information centre.

Visit our shareholder centre

Case study: Improving the customer experience in China

Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

Financial performance and KPIs

View our most recent financial results and key performance indicators.

Find out more

Results, presentations and reports

View our results collateral and archive.

Find out more

Financial results and past events

Half year 2022 results

Excellent first half performance driving profit growth

Find out more

Half year 2022 results

Listen on demand to our half year results, 29 July 2022

Listen on demand

Investor news

Sustainability expert Aris Vrettos joins Croda

The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

U.S. Government to support expansion of Croda lipid systems capability

Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines